Select transition zone prostate cancers may be radiocurable despite markedly elevated prostate-specific antigen levels.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8850429.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 1993, three men with transition zone prostate cancers were described (Stamey et al., J. Urol. 149: 510-515, 1993) who despite high prostate-specific antigen (PSA) levels remained PSA failure-free at 22 months postoperatively. This report illustrates that prolonged PSA failure free survival may be achieved when external beam radiation therapy is used to treat similar patients.
Medical subject headings
- Adenocarcinoma
- Prostate-Specific Antigen
- Prostatic Neoplasms
- Radiotherapy, High-Energy